The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
My mistake. Still it's looking good. GLALTH
Patients - Like aforementioned it would be utter insanity to add an extra 80 patients and another hospital on if this wasn't working. Patience - Of course I lack this and made the mistake of selling some shares a few weeks back to try and trade something else quickly, made a small but not substantial profit, however bought back in today at a higher price and increased position, cost myself around £300-400 messing around. Patents - The recent patent by William Bachovchin.
Thanks Tom, This is true. I had to leave out details of their other ventures from the post because they have their fingers in so many pies!
The thing I love is that even being conservative and perhaps pessimistic, I see so much up-side that I keep buying even though I'm heavily weighted in the stock. At times I bang my head against a wall that others can't see / can't be bothered to research what is so obvious!
Avacta will either be taken out or turn into a large Pharma in their own right.
The company is building out an excellent line of therapeutics and licence agreements and one assumes that if AVA 6000 is successful the PRE|Cision tech behind it should successfully transfer to the other lines?. It's no coincidence that they have just moved into the same neck of the woods are that Takeda are based with their drug Velcade (Bortezomib) coming off patent soon and this being what the 3996 trial will target. A licensing agreement to extend that patent is surely on the cards...
Either way as each piece comes together, the value of any potential T/O rises. Already I personally believe £10b + to be a given when working out the simple maths of what licensing deals for the pipeline would generate.
Anyway GLA long term holders, as I've stated in previous posts I'm still topping up as and when I can afford to.
Dear Avacta,
I have a fairly large position already (16,544 shares) at a higher average but I’ve just had a big dentist bill for this month come through.
If we could please stay low for just a short while longer so I can get some money together to buy a couple thousand more on payday then that would be much appreciated.
Many thanks! ??
Ben
Just thought would pop a message here to say that like many, I am also sitting on a large theoretical paper loss (54%) but nothings changed in my mind. If anything my conviction has only got stronger. This is an opportunity to hoover up cheap shares and HODL for long term. I still strongly believe that anyone who purchases now will be looking at an 80x or £40 share within 3 years. That's if they're not taken out of course.
We will all look back on this with hindsight and think **** why didn't I purchase more. But anyway just my 2 cents...GLA.
About any new buyers jumping in from today. They have a 60x opportunity with a strong chance of this happening within 3 years (or sooner). There’s not many investments you can say that about.
Looking forward to payday where my holding will be increased further, and every month after until this is back north of a couple of pounds.
This period of price volatility really is a blessing for the long term holder. The big ‘if’ was always if the pre|CISION technology works in humans, imo it looks like it does based on the escalating of doses.
From this one drug line with an increased market share because of efficacy this one line alone could amount to £2.1 billlion in revenue per year x 0.3 (30% standard royalty) and you’re looking at £700 million for Avacta every year give or take.
X14 (standard P/E for Bio comps) and you’ve got a company that could be valued between 8-10 Billion or £35 - £40 a share.
Anyway don’t post on here much but that’s why I’m in this share, I really don’t care about small fluctuations, MM’s and have done my research. GLA, sentiment will change on this share soon and when it does we’ll have the last laugh.
Really wanting AVCT to stop rising before this weekend / people connect the dots ??.
Guys this really is a fantastic business and I personally believe it will quickly multiple from its small market cap just from a UK govt order alone / to potentially be a NASDAQ listing if a capital manager wakes up to it's potential.
Don't get me wrong I have a respectable holding already but have recently placed my assets into Bitcoin, Ethereum, Beyond Meat, Aston Martin and Fiverr. Now from all of these I have achieved +40% gains in a few weeks / months but I get paid again on Friday and want one last chance to load up before this share goes to the moon.
GLA going into next week and all I will say is that this is an easy bagger with a massive backup plan as COVID is not the real breadwinner here, the cancer diagnostics division perhaps is?. Not to mention the other strings in it's bow.
Cheers all, GL again,
-B
Good evening board,
Just to clarify I am a long term holder and not in this stock for the COVID play but just wanted to share this.
I work for Royal Mail and we have been briefed that we will need to work on Sunday's fairly soon to help meet the demand for COVID testing. What I do know is we are waiting for the government approval on when these tests are ready but it is not until the week of the 22/02 where we will find out more information.
I personally know that this contract must be huge as all staff have been alerted and they will be paying us a great rate to deliver these tests on Sundays as a matter of national urgency. Is this perhaps a potential Avacta test which I hear the gvmnt is also planning an announcement of on the week of the 22nd?
May sound like speculation so sorry if it does but would link perfectly for a start of march national rollout of these tests?.
Would be interested to hear your opinions.
GLA investors,
Many thanks
Ben
Hello all,
Just wanted to give my two cents being an investor from early 2020 in Avacta.
Please correct me if I am wrong but as far as I can see a lot of investors are missing the bigger picture. Covid treatment has the opportunity to bring in fantastic revenues and propel the company to new income goals, however.
The biggest play they have on their hands is their targeted cancer therapies. A lot of what AVCT are currently offering would target cancer treatments that are currently costing £250k per course of treatment and drastically improve not only chances of survival but cost savings for healthcare for pharmaceutical providers. There is a lot of sourness on this board from derampers etc but lets please all take a second for reflection and think not what this share is worth based on COVID and what it should actually be valued at as a challenger to major pharmas for cancer treatment.
GLA,
B ...??
As a 26 year old who is highly invested in innovative tech companies I wanted to give my 2 cents as to why AML is such a great buy right now.
Aston is a steal right now, nothing more nothing less.
- Mercedes investment and potential electric technology underpinning company.
- Tobias Myers who turned around Mercedes AMG is now CEO.
- Flagship F1 driver who has won 4 world championships marketing brand (now also a share holder).
- Toto Wolff now also a shareholder.
- Aspirational luxury brand marketed by the liked of Rick Ross (Aston Martin Music).
- Upcoming James Bond movie which will only help brand promotion further.
- All of my close friends aspire to drive Astons when we get rich.
- New DBX model rated highly by top gear and others who have tested it.
I've probably even missed other points from this list but unless there is some sort of small share holder didling I am very confident in Astons future and think once old rony rona's done with we will come out of this shining.
GLA.